Company Interview / Cogstate (ASX: CGS) Investor Presentation

Cogstate (ASX: CGS), an Australian neuroscience technology company which provides digital brain health assessments and services to advance drug development and enable early clinical insights in healthcare. Cogstate operates globally, offering a platform of cognitive testing tools and support services for clinical trials, particularly in pharmaceuticals and biotechnology. Cogstate (ASX: COG) is expanding into healthcare solutions, presenting a unique investment opportunity in the growing neuroscience and health technology sectors.

CEO Brad O'Connor expands on how Cogstate (ASX:COG) is advancing drug development through digital health assessments. Brad highlights Cogstate's financials and shareholder scheme. Watch for the company's plans to expand its global presence, expecting sustained revenue growth and profitability.*The information contained in this event is general in nature and is not intended as advice. Before acting on information you've seen or heard at this event, you should seek professional financial advice which takes into account your personal circumstances.

You should be aware that companies presenting do so under commercial agreement with AUSBIZ CAPITAL PTY LTD